Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Protokinetix Inc (PKTX)

Protokinetix Inc (PKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PKTX with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0141 +34.75%
on 04/02/24
0.0199 -4.52%
on 04/01/24
+0.0016 (+9.20%)
since 03/21/24
3-Month
0.0130 +46.15%
on 02/22/24
0.0210 -9.52%
on 02/22/24
+0.0013 (+7.34%)
since 01/24/24
52-Week
0.0101 +88.12%
on 10/18/23
0.0300 -36.67%
on 09/19/23
-0.0089 (-31.90%)
since 04/24/23

Most Recent Stories

More News
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that the University of Alberta has successfully...

PKTX : 0.0190 (+2.15%)
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that it will hold its Annual General Meeting...

PKTX : 0.0190 (+2.15%)
ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that it has selected two formulations of its...

PKTX : 0.0190 (+2.15%)
ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced its collaboration with IQVIA (NYSE: IQV ) to...

PKTX : 0.0190 (+2.15%)
IQV : 240.84 (+0.93%)
ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX) , a clinical-stage biomedical company, today announced Phase I clinical trials of AAGP® (PKX-001) treated...

PKTX : 0.0190 (+2.15%)
ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®

ProtoKinetix, Incorporated (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that it has engaged a global pharmaceutical company to develop the formulation...

PKTX : 0.0190 (+2.15%)
Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced the publication of a peer reviewed research paper...

PKTX : 0.0190 (+2.15%)
Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced the submission of a research paper describing...

PKTX : 0.0190 (+2.15%)
ProtoKinetix AAGP® Restores Vision in Blind Test Subjects

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that after the conclusion of 4-years of extensive...

PKTX : 0.0190 (+2.15%)
Ammendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials Have Been Approved by Health Canada

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced that Dr. James Shapiro has received approval...

PKTX : 0.0190 (+2.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ProtoKinetix, Incorporated, a development stage company, was incorporated under the laws of the State of Nevada on December 23, 1999. It is a medical research company whose mission is the advancement of human health care. The Company has developed a body of trade secrets and know-how relating to the...

See More

Key Turning Points

3rd Resistance Point 0.0243
2nd Resistance Point 0.0217
1st Resistance Point 0.0203
Last Price 0.0190
1st Support Level 0.0163
2nd Support Level 0.0137
3rd Support Level 0.0123

See More

52-Week High 0.0300
Fibonacci 61.8% 0.0224
Fibonacci 50% 0.0201
Last Price 0.0190
Fibonacci 38.2% 0.0177
52-Week Low 0.0101

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar